BERLIN – Severe hypoglycemia was reversed successfully in all patients with type 1 diabetes mellitus given nasal glucagon.
Mortality declined dramatically in patients with type 2 diabetes mellitus who took the medication over an average of 3 years.
BERLIN – LeucoPatch, which contains patients’ own platelets, fibrin, and leukocytes, enabled more diabetic ulcers to heal versus standard care.
The appetite-suppressant drug lorcaserin has benefits ranging from lower rates of incident type 2 diabetes mellitus and improved glycemic control...
BERLIN – The ADA and EASD have issued their 2018 Consensus Report on the management of hyperglycemia in type 2 diabetes.
BERLIN – HbA1c and body weight were significantly lowered, compared with placebo and dulaglutide, by the dual GIP/GLP-1 receptor agonist LY3298176...
BERLIN – Gastric banding surgery and metformin improved insulin sensitivity, suggestive of preserved beta-cell function.
Women with type 2 diabetes mellitus have a moderately increased risk of breast cancer that appears to be mainly caused by adiposity, not diabetes...
Gastric bypass surgery lowers the risk of all-cause mortality and cardiovascular disease, but the risk for a number of short-term complications is...
Revised protocol increased diagnoses, but also increased insulin use and pregnancy outcomes including labor induction and neonatal hyperglycemia...
ORLANDO – Most type 2 diabetes mellitus patients discontinue their medication within a year.
Statins for primary prevention may benefit older patients, if diabetes is present.
Podiatrist says it’s not enough to get a culture biopsy on its own; genetic sequencing may play a role in future.
“Increasing the availability of glucagon in the prehospital setting will likely result in reduced cost burden and adverse consequences of severe...
The test improved predictive performance when added to conventional risk factors.
ORLANDO – Draft recommendations for hyperglycemia management in T2DM were released at the scientific sessions of the ADA.
Final VADT follow-up study results show no legacy effect for CV or renal outcomes at 15 years in the intensive glucose therapy arm.
Smoking cessation and other steps to manage cardiovascular risk can help improve the long-term outlook for patients with type 2 diabetes mellitus...
